Recent News

• 09.19.2025 - Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
• 09.19.2025 - Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
• 09.18.2025 - Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
• 09.18.2025 - Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference 2025
• 09.03.2025 - Cantor Fitzgerald Global Healthcare Conference 2025
• 08.27.2025 - Jasper Therapeutics to Present at Upcoming Investor Conferences
• 08.27.2025 - Jasper Therapeutics to Present at Upcoming Investor Conferences

Recent Filings

• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2025 - 8-K Current report
• 08.13.2025 - EX-99.1 EX-99.1
• 08.06.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.11.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors